Suppr超能文献

超声引导下高渗葡萄糖腱内注射治疗跟腱慢性肌腱病:一项前瞻性研究。

Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study.

作者信息

Maxwell Norman J, Ryan Michael B, Taunton Jack E, Gillies Jean H, Wong Anthony D

机构信息

Department of Radiology, St. Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada.

出版信息

AJR Am J Roentgenol. 2007 Oct;189(4):W215-20. doi: 10.2214/AJR.06.1158.

Abstract

OBJECTIVE

Chronic tendinosis of the Achilles tendon is a common overuse injury that is difficult to manage. We report on a new injection treatment for this condition.

SUBJECTS AND METHODS

Thirty-six consecutive patients (25 men, 11 women; mean age, 52.6 years) with symptoms for more than 3 months (mean, 28.6 months) underwent sonography-guided intratendinous injection of 25% hyperosmolar dextrose every 6 weeks until symptoms resolved or no improvement was shown. At baseline and before each injection, clinical assessment was performed using a visual analogue scale (VAS) for pain at rest (VAS1), pain during normal daily activity (VAS2), and pain during or after sporting or other physical activity (VAS3). Sonographic parameters including tendon thickness, echogenicity, and neovascularity were also recorded. Posttreatment clinical follow-up was performed via telephone interview.

RESULTS

Thirty-three tendons in 32 patients were successfully treated. The mean number of treatment sessions was 4.0 (range, 2-11). There was a mean percentage reduction for VAS1 of 88.2% (p < 0.0001), for VAS2 of 84.0% (p < 0.0001), and for VAS3 of 78.1% (p < 0.0001). The mean tendon thickness decreased from 11.7 to 11.1 mm (p < 0.007). The number of tendons with anechoic clefts or foci was reduced by 78%. Echogenicity improved in six tendons (18%) but was unchanged in 27 tendons (82%). Neovascularity was unchanged in 11 tendons (33%) but decreased in 18 tendons (55%); no neovascularity was present before or after treatment in the four remaining tendons. Follow-up telephone interviews of the 30 available patients a mean of 12 months after treatment revealed that 20 patients were still asymptomatic, nine patients had only mild symptoms, and one patient had moderate symptoms.

CONCLUSION

Intratendinous injections of hyperosmolar dextrose yielded a good clinical response--that is, a significant reduction in pain at rest and during tendon-loading activities--in patients with chronic tendinosis of the Achilles tendon.

摘要

目的

跟腱慢性肌腱病是一种常见的过度使用损伤,难以治疗。我们报告一种针对这种病症的新型注射治疗方法。

受试者与方法

36例连续患者(25名男性,11名女性;平均年龄52.6岁),症状持续超过3个月(平均28.6个月),每6周接受超声引导下腱内注射25%高渗葡萄糖,直至症状缓解或无改善。在基线及每次注射前,使用视觉模拟量表(VAS)对静息痛(VAS1)、日常正常活动时的疼痛(VAS2)以及运动或其他体力活动期间或之后的疼痛(VAS3)进行临床评估。还记录了包括肌腱厚度、回声性和新生血管等超声参数。治疗后通过电话访谈进行临床随访。

结果

32例患者的33条肌腱成功接受治疗。平均治疗次数为4.0次(范围2 - 11次)。VAS1平均降低百分比为88.2%(p < 0.0001),VAS2为84.0%(p < 0.0001),VAS3为78.1%(p < 0.0001)。平均肌腱厚度从11.7毫米降至11.1毫米(p < 0.007)。出现无回声裂隙或病灶的肌腱数量减少了78%。6条肌腱(18%)的回声性改善,27条肌腱(82%)未改变。11条肌腱(33%)的新生血管未改变,18条肌腱(55%)减少;其余4条肌腱治疗前后均无新生血管。对30例可联系到的患者在治疗后平均12个月进行电话随访,结果显示20例患者仍无症状,9例患者仅有轻微症状,1例患者有中度症状。

结论

对于跟腱慢性肌腱病患者,腱内注射高渗葡萄糖产生了良好的临床反应,即静息痛和肌腱负荷活动时的疼痛显著减轻。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验